Page last updated: 2024-08-26

uftoral and Biliary Tract Cancer

uftoral has been researched along with Biliary Tract Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furuse, J; Ikeda, M; Ishii, H; Morizane, C; Okusaka, T; Ueno, H	1

Trials

1 trial(s) available for uftoral and Biliary Tract Cancer

Article	Year
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:8 Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Quality of Life; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory	2005

Article

Year

A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.

Japanese journal of clinical oncology, 2005, Volume: 35, Issue:8

Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Quality of Life; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory

2005